{
    "organizations": [],
    "uuid": "6f85b7e6975b2f76bad41c631682e2341599f133",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jubilant-life-sciences-says-unit-g/brief-jubilant-life-sciences-says-unit-got-anda-approval-for-amantadine-hydrochloride-tablets-idUSFWN1PY1RJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Jubilant Life Sciences Says Unit Got ANDA Approval For Amantadine Hydrochloride Tablets​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 9 (Reuters) - Jubilant Life Sciences Ltd:\n* UNIT, JUBILANT PHARMA GETS ANDA FINAL APPROVAL FOR AMANTADINE HYDROCHLORIDE TABLETS, GENERIC VERSION OF SYMMETREL OF ENDO​ Source text: bit.ly/2EtLooJ Further company coverage:\n ",
    "published": "2018-02-09T14:31:00.000+02:00",
    "crawled": "2018-02-10T14:22:01.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "jubilant",
        "life",
        "science",
        "ltd",
        "unit",
        "jubilant",
        "pharma",
        "get",
        "anda",
        "final",
        "approval",
        "amantadine",
        "hydrochloride",
        "tablet",
        "generic",
        "version",
        "symmetrel",
        "source",
        "text",
        "company",
        "coverage"
    ]
}